ProQuest Financial LLC is 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX). They have made 6 open-market trades across 1 company since 2016, most recently 2017-04-03.
CIK 0001674772
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EGRX | 3,584,087 | $7.7M |
Shares reported on the most recent Form 4, priced at the 2017-04-03 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 67% | 33% |
| Avg Move | +0.6% | +2.2% | +22.0% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EGRX | SELL | 2017-03-30 | 2017-04-03 | $83.10 | $14.7M | +4.7% | +5.6% | -3.9% |
| EGRX | SELL | 2017-03-21 | 2017-03-23 | $83.05 | $100K | +3.4% | +8.2% | -1.5% |
| EGRX | SELL | 2016-08-17 | 2016-08-17 | $61.19 | $603K | -1.1% | -0.1% | +34.3% |
| EGRX | SELL | 2016-08-16 | 2016-08-17 | $61.08 | $1.7M | -1.1% | -0.1% | +34.3% |
| EGRX | SELL | 2016-08-15 | 2016-08-17 | $61.36 | $6.1M | -1.1% | -0.1% | +34.3% |
| EGRX | SELL | 2016-08-15 | 2016-08-17 | $60.51 | $1.0M | -1.1% | -0.1% | +34.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.